|
|
Post by liane on Feb 18, 2014 19:13:15 GMT -5
|
|
|
|
Post by babaoriley on Feb 18, 2014 22:54:32 GMT -5
Well, I never did find that Shoutbox, Liane, but overall, I felt the presentation was fine. It certainly has become clear to me that only about a 20% chance remains of partnership before AdCom, to that's too bad, at least for my intended strategy.
Al is like a bull in a China shop, Hakam is anything but that, however, he does seem to be impolitic in certain statements, my guess may be that English is not his first language. Toward the end of the question period, why mention "correcting" Al, when he could have said, "in addition" or "supplementing?" I'm sure Al gave him a look or two during the presentation.
Will we get a full blown attack by AF and his ilk tomorrow?
I'm in a stock called Prana (PRAN), it's very volatile, had some news on a trial today that the company called good, but AF called it a failed Phase 2 trial, which proved very little (I'm sure the truth lies somewhere in between). Stock went up from about $8 to a little over $10 today - I did enjoy AF having to eat his words silently, of course (for now, who knows what happens even tomorrow!).
|
|
|
|
Post by thsloppy on Feb 19, 2014 8:00:18 GMT -5
Call was really a non event again. I think the only solid pieces of information were the release of the full data at the ADA Scientific Session (and publication), that Deerfield fully exercised and that they are ramping up for a launch within 6 months of FDA approval. Good signs that keep me off the ledge. The elephant in the room continues to remain with a lack of partnership with the AdCom and FDA date within 2 months. Al's rant about patents, which is something most of us largely know, was a planned deflection to having no news on partners IMHO. Trying to read the tea leaves, they are ramping up for a full launch "within 6 months" after approval. This means they would need a partner fairly soon to be able to execute that. Maybe we will be pleasantly surprised and see something between now and then.
|
|
|
|
Post by ezrasfund on Feb 19, 2014 8:23:59 GMT -5
It was good to hear that certain top line data is being withheld because it is so significant, not bad, and will be published in scientific journals. Also MNKD has successfully executed their financing options and has plenty of cash on hand. Deerfield's vote of confidence is encouraging.
In similar fashion to the data being withheld, I believe partnership is being held back because Afrezza is so very safe and effective, and there are plenty of potential partners. Hakan said they would require a sales force of 1000, including reps,support staff and educators. As for the schedule on the road to partnership, they are pleased with the work Greenfield is doing, and "we have deadlines and performance target dates" that are apparently being met. Al and his crew seemed to be very upbeat (although the laughter at the beginning of the call was probably due to the mispronunciation of Matt's name.) So relax, there will be "further communication in the coming weeks."
|
|
|
|
Post by rak5555 on Feb 19, 2014 9:01:53 GMT -5
sloppy "Al's rant about patents, which is something most of us largely know, was a planned deflection to having no news on partners IMHO"
I totally agree.
|
|
